What is the primary treatment approach for SJS?

The primary treatment approach for Stevens-Johnson Syndrome (SJS) is often to admit the patient to a burn unit or a specialized hospital that can provide critical care and manage severe skin and mucosal involvement. This is essential because SJS can lead to significant skin loss and complications that resemble severe burns, necessitating advanced wound care and monitoring in a controlled environment.

Being admitted to a burn unit provides access to medical professionals experienced in treating extensive epidermal detachment, managing fluid and electrolyte balance, and preventing infections. It is also critical for managing complications such as secondary infections, sepsis, and supporting the patient during the recovery process.

Other treatment options like topical corticosteroids, antibiotics, and immunosuppressants may play roles in managing specific symptoms or underlying causes but are not the primary approach to treat SJS itself. For instance, topical corticosteroids may be used, but their efficacy in SJS is debated, and immunosuppressants are usually reserved for other severe dermatological conditions. Antibiotics might be necessary if there are secondary infections, but they do not address the core issue of SJS.